Trial Profile
Tolterodine extended-release (ER) versus standard-dose pregabalin + tolterodine ER versus low-dose pregabalin + tolterodine ER versus pregabalin alone in female patients with idiopathic overactive bladder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Mar 2011
Price :
$35
*
At a glance
- Drugs Tolterodine (Primary) ; Pregabalin
- Indications Overactive bladder
- Focus Therapeutic Use
- 25 Mar 2011 New trial record